Literature DB >> 16805777

The genetics of neurodegenerative diseases.

John Hardy1, Harry Orr.   

Abstract

In the last 50 years, an enormous amount of progress has been made in dissecting the etiology of hereditary neurodegenerative diseases, including the dementias, the parkinsonisms, the ataxias and the motor-neuron diseases. In addition, these genetic findings are beginning to provide insights into the pathogeneses of the sporadic forms of the diseases. Through animal and cellular modeling studies we are beginning to gain insights into the pathogenic pathways to disease. This mechanistic understanding is now leading to therapeutic strategies based on this new understanding. As yet, however, no mechanistic therapies are in use in the clinic.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16805777     DOI: 10.1111/j.1471-4159.2006.03979.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  25 in total

Review 1.  Nuclear ataxias.

Authors:  Harry T Orr
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-05       Impact factor: 10.005

Review 2.  Unique biology of gliomas: challenges and opportunities.

Authors:  Stacey Watkins; Harald Sontheimer
Journal:  Trends Neurosci       Date:  2012-06-08       Impact factor: 13.837

Review 3.  Evolution of neurodegeneration.

Authors:  Mark R Cookson
Journal:  Curr Biol       Date:  2012-09-11       Impact factor: 10.834

4.  Synthesis, stereochemical analysis, and derivatization of myricanol provide new probes that promote autophagic tau clearance.

Authors:  Mackenzie D Martin; Laurent Calcul; Courtney Smith; Umesh K Jinwal; Sarah N Fontaine; April Darling; Kent Seeley; Lukasz Wojtas; Malathi Narayan; Jason E Gestwicki; Garry R Smith; Allen B Reitz; Bill J Baker; Chad A Dickey
Journal:  ACS Chem Biol       Date:  2015-01-30       Impact factor: 5.100

5.  The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.

Authors:  Umesh K Jinwal; Justin H Trotter; Jose F Abisambra; John Koren; Lisa Y Lawson; Grant D Vestal; John C O'Leary; Amelia G Johnson; Ying Jin; Jeffrey R Jones; Qingyou Li; Edwin J Weeber; Chad A Dickey
Journal:  J Biol Chem       Date:  2011-03-02       Impact factor: 5.157

6.  Inhibition of Both Hsp70 Activity and Tau Aggregation in Vitro Best Predicts Tau Lowering Activity of Small Molecules.

Authors:  Mackenzie D Martin; Jeremy D Baker; Amirthaa Suntharalingam; Bryce A Nordhues; Lindsey B Shelton; Dali Zheng; Jonathan J Sabbagh; Timothy A J Haystead; Jason E Gestwicki; Chad A Dickey
Journal:  ACS Chem Biol       Date:  2016-05-26       Impact factor: 5.100

7.  Aging analysis reveals slowed tau turnover and enhanced stress response in a mouse model of tauopathy.

Authors:  Chad Dickey; Clara Kraft; Umesh Jinwal; John Koren; Amelia Johnson; Laura Anderson; Lori Lebson; Daniel Lee; Dennis Dickson; Rohan de Silva; Lester I Binder; David Morgan; Jada Lewis
Journal:  Am J Pathol       Date:  2008-12-12       Impact factor: 4.307

Review 8.  RNA-binding proteins implicated in neurodegenerative diseases.

Authors:  Mark R Cookson
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-09-23       Impact factor: 9.957

9.  Unbiased screen reveals ubiquilin-1 and -2 highly associated with huntingtin inclusions.

Authors:  Nicola J Rutherford; Jada Lewis; Amy K Clippinger; Michael A Thomas; Jennifer Adamson; Pedro E Cruz; Ashley Cannon; Guilian Xu; Todd E Golde; Gerry Shaw; David R Borchelt; Benoit I Giasson
Journal:  Brain Res       Date:  2013-06-15       Impact factor: 3.252

10.  Tauopathy with paired helical filaments in an aged chimpanzee.

Authors:  Rebecca F Rosen; Aaron S Farberg; Marla Gearing; Jeromy Dooyema; Patrick M Long; Daniel C Anderson; Jeremy Davis-Turak; Giovanni Coppola; Daniel H Geschwind; Jean-Francois Paré; Timothy Q Duong; William D Hopkins; Todd M Preuss; Lary C Walker
Journal:  J Comp Neurol       Date:  2008-07-20       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.